![Exploring CAR T-cell therapy and second cancers with Stephanie Goff on NCI’s Cancer Currents blog – NCI Center for Cancer Research](https://oncodaily.com/pub/uploads/2024/08/s._goff_-_2015_235x235_px-1-e1723824960981.png)
Exploring CAR T-cell therapy and second cancers with Stephanie Goff on NCI’s Cancer Currents blog – NCI Center for Cancer Research
NCI Center for Cancer Research shared on LinkedIn:
“Cancer Currents: In this Q and A, Stephanie Goff, Senior Research Physician in our Surgery Branch, talks about what’s known about CAR T-cell therapy and second cancers and what this issue means in general for patients and this area of research. Dr. Goff specializes in developing and testing gene-engineered T-cell therapies, including CARs.
Source: NCI Center for Cancer Research/LinkedIn
Stephanie L. Goff, MD, FACS, is a Senior Research Physician and surgical oncologist, serving as the Head of Clinical Operations in the Surgery Branch at the National Cancer Institute, NIH. She specializes in cell therapy for cancer, particularly focusing on tumor-infiltrating lymphocytes.
Her research is centered on adoptive cell therapy for solid tumors and developing treatments for patients with treatment-resistant metastatic melanoma.